α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Neurodegenerative Diseases ; 14 (2013), 1. - S. 1-17. - ISSN 1660-2854. - eISSN 1660-2862
- Schlagwort
-
Parkinson-Krankheit
Substantia nigra
Synuclein
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2013
- Urheber
-
Eschbach, Judith
Danzer, Karin M.
- DOI
-
10.18725/OPARU-40456
- URN
-
urn:nbn:de:bsz:289-oparu-40532-6
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eschbach, Judith
- Danzer, Karin M.
- Universität Ulm
Entstanden
- 2013
Ähnliche Objekte (12)
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Increased immune activation by pathologic α‐synuclein in parkinson's disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease